| pubmed-article:17845935 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17845935 | lifeskim:mentions | umls-concept:C0042153 | lld:lifeskim |
| pubmed-article:17845935 | lifeskim:mentions | umls-concept:C0024128 | lld:lifeskim |
| pubmed-article:17845935 | lifeskim:mentions | umls-concept:C0751674 | lld:lifeskim |
| pubmed-article:17845935 | lifeskim:mentions | umls-concept:C0542331 | lld:lifeskim |
| pubmed-article:17845935 | lifeskim:mentions | umls-concept:C0023866 | lld:lifeskim |
| pubmed-article:17845935 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
| pubmed-article:17845935 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
| pubmed-article:17845935 | lifeskim:mentions | umls-concept:C1442858 | lld:lifeskim |
| pubmed-article:17845935 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:17845935 | pubmed:dateCreated | 2007-9-11 | lld:pubmed |
| pubmed-article:17845935 | pubmed:abstractText | Chylous effusions are a well-described complication of lymphangioleiomyomatosis (LAM) in both pre- and post-transplant patients. Chylous effusions can cause significant morbidity among patients and most treatment modalities have limitations to complete success. We describe the use of a pleurovenous shunt to treat a refractory chylous effusion in a patient after lung transplant for LAM. After shunt placement, the patient had complete resolution of the chylous effusion and subsequent discharge home after a prolonged hospitalization. The use of a pleurovenous shunt for refractory chylous effusions is a viable option after conventional therapy fails. | lld:pubmed |
| pubmed-article:17845935 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17845935 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17845935 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17845935 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17845935 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:17845935 | pubmed:issn | 1557-3117 | lld:pubmed |
| pubmed-article:17845935 | pubmed:author | pubmed-author:LightRichard... | lld:pubmed |
| pubmed-article:17845935 | pubmed:author | pubmed-author:MilstoneAaron... | lld:pubmed |
| pubmed-article:17845935 | pubmed:author | pubmed-author:NinanMathewM | lld:pubmed |
| pubmed-article:17845935 | pubmed:author | pubmed-author:FremontRichar... | lld:pubmed |
| pubmed-article:17845935 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17845935 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:17845935 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17845935 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17845935 | pubmed:pagination | 953-5 | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:meshHeading | pubmed-meshheading:17845935... | lld:pubmed |
| pubmed-article:17845935 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17845935 | pubmed:articleTitle | Chylothoraces after lung transplantation for lymphangioleiomyomatosis: review of the literature and utilization of a pleurovenous shunt. | lld:pubmed |
| pubmed-article:17845935 | pubmed:affiliation | Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2650, USA. richard.fremont@vanderbilt.edu | lld:pubmed |
| pubmed-article:17845935 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17845935 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:17845935 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17845935 | lld:pubmed |
